Who are Crystalline Calcium Carbonate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Tums, Milk of Magnesia, NaHCO3, MINTOX® Maximum Strength, Oral Maalox/ Mylanta, Experimental - 4% Sodium Bicarbonate.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/crystalline-calcium-carbonate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Crystalline Calcium Carbonate — Competitive Intelligence Brief

Crystalline Calcium Carbonate (Crystalline Calcium Carbonate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antacid. Area: Gastrointestinal.

phase 2 Antacid Gastrointestinal Small molecule Live · refreshed every 30 min

Target snapshot

Crystalline Calcium Carbonate (Crystalline Calcium Carbonate) — Amorphical Ltd.. Crystalline Calcium Carbonate works by neutralizing stomach acid.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Crystalline Calcium Carbonate TARGET	Crystalline Calcium Carbonate	Amorphical Ltd.	phase 2	Antacid
Tums	calcium carbonate	Generic (multiple manufacturers)	marketed	Antacid, Calcium supplement	Gastric acid (direct neutralization)	1930-01-01
Milk of Magnesia	magnesium hydroxide	Generic (multiple manufacturers)	marketed	Osmotic laxative, Antacid	Gastric acid (direct neutralization) + osmotic effect in intestine	1880-01-01
NaHCO3	NaHCO3	Karadeniz Technical University	marketed	Antacid / Alkalizing agent
MINTOX® Maximum Strength	MINTOX® Maximum Strength	Merck Sharp & Dohme LLC	marketed	Antacid
Oral Maalox/ Mylanta	Oral Maalox/ Mylanta	Stony Brook University	marketed	Antacid combination
Experimental - 4% Sodium Bicarbonate	Experimental - 4% Sodium Bicarbonate	Baptist Health South Florida	marketed	Antacid / Alkalinizing agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antacid class)

Amorphical Ltd. · 1 drug in this class
Bosnalijek D.D · 1 drug in this class
HALEON · 1 drug in this class
Isfahan University of Medical Sciences · 1 drug in this class
Merck Sharp & Dohme LLC · 1 drug in this class
POZEN · 1 drug in this class
Western Galilee Hospital-Nahariya · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Crystalline Calcium Carbonate — Competitive Intelligence Brief. https://druglandscape.com/ci/crystalline-calcium-carbonate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab